Literature DB >> 2845215

Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone.

M C Luke1, E F Hahn, M Price, G W Pasternak.   

Abstract

We have synthesized a series of hydrazones and acylhydrazones of naltrexone. These substitutions had modest effects on competition of mu binding but many greatly enhanced the relative potency of the compounds for delta receptors. Increased delta affinity was most prominent with the acylhydrazones. Many of the derivatives elicited a wash-resistant inhibition of binding which was restricted to mu, not delta, binding sites. This wash-resistant inhibition of binding did not correlate with affinity, as determined by IC50 values, implying that the inhibition could not be explained simply by slow rate of dissociation due to increased affinity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845215     DOI: 10.1016/0024-3205(88)90215-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 2.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.

Authors:  M A King; S Bradshaw; A H Chang; J E Pintar; G W Pasternak
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

4.  Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist.

Authors:  G J Alexander; N Chatterjie
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

5.  Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA.

Authors:  Steven G Grinnell; Susruta Majumdar; Ankita Narayan; Valerie Le Rouzic; Michael Ansonoff; John E Pintar; Gavril W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  2014-06-26       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.